These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32064939)

  • 1. Green synthesis of bioactive oligopeptides promoted by recyclable nanocrystalline hydroxyapatite.
    Anselmi M; Stavole P; Boanini E; Bigi A; Juaristi E; Gentilucci L
    Future Med Chem; 2020 Mar; 12(6):479-491. PubMed ID: 32064939
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
    J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential receptor binding characteristics of consecutive phenylalanines in micro-opioid specific peptide ligand endomorphin-2.
    Honda T; Shirasu N; Isozaki K; Kawano M; Shigehiro D; Chuman Y; Fujita T; Nose T; Shimohigashi Y
    Bioorg Med Chem; 2007 Jun; 15(11):3883-8. PubMed ID: 17395470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex.
    Hackler L; Zadina JE; Ge LJ; Kastin AJ
    Peptides; 1997; 18(10):1635-9. PubMed ID: 9437727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferred conformation of endomorphin-1 in aqueous and membrane-mimetic environments.
    Fiori S; Renner C; Cramer J; Pegoraro S; Moroder L
    J Mol Biol; 1999 Aug; 291(1):163-75. PubMed ID: 10438613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of naturally occurring and synthetic opioid tetrapeptides acting on locus coeruleus neurons.
    Yang YR; Chiu TH; Chen CL
    Eur J Pharmacol; 1999 May; 372(3):229-36. PubMed ID: 10395016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endomorphin 1[psi] and endomorphin 2[psi], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception.
    Zhao QY; Chen Q; Yang DJ; Feng Y; Long Y; Wang P; Wang R
    Life Sci; 2005 Jul; 77(10):1155-65. PubMed ID: 15878600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis and mu-opioid receptor affinity of short peptides, endomorphin models in a low polarity solvent.
    Cardillo G; Gentilucci L; Tolomelli A; Qasem AR; Spampinato S; Calienni M
    Org Biomol Chem; 2003 Sep; 1(17):3010-4. PubMed ID: 14518122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Energy Conformations for Endogenous Mu-Receptor-Specific Peptides.
    Lin B; Carty RP; Pincus MR
    Protein J; 2020 Jun; 39(3):217-223. PubMed ID: 32449111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of the endogenous mu-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling.
    Podlogar BL; Paterlini MG; Ferguson DM; Leo GC; Demeter DA; Brown FK; Reitz AB
    FEBS Lett; 1998 Nov; 439(1-2):13-20. PubMed ID: 9849868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and binding activity of endomorphin-1 analogues containing beta-amino acids.
    Cardillo G; Gentilucci L; Melchiorre P; Spampinato S
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2755-8. PubMed ID: 11133084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of stereoisomeric analogues of endomorphin-2, H-Tyr-Pro-Phe-Phe-NH(2), and examination of their opioid receptor binding activities and solution conformation.
    Okada Y; Fukumizu A; Takahashi M; Shimizu Y; Tsuda Y; Yokoi T; Bryant SD; Lazarus LH
    Biochem Biophys Res Commun; 2000 Sep; 276(1):7-11. PubMed ID: 11006073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid peptides endomorphin-2/DAMGO: design, synthesis and biological evaluation.
    Mollica A; Costante R; Stefanucci A; Pinnen F; Luisi G; Pieretti S; Borsodi A; Bojnik E; Benyhe S
    Eur J Med Chem; 2013 Oct; 68():167-77. PubMed ID: 23974016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.
    Fichna J; do-Rego JC; Janecki T; Staniszewska R; Poels J; Broeck JV; Costentin J; Schiller PW; Janecka A
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1350-3. PubMed ID: 18207400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endomorphin-2 analogs containing modified tyrosines: Biological and theoretical investigation of the influence on conformation and pharmacological profile.
    Wtorek K; Artali R; Piekielna-Ciesielska J; Koszuk J; Kluczyk A; Gentilucci L; Janecka A
    Eur J Med Chem; 2019 Oct; 179():527-536. PubMed ID: 31276897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel non-opioid binding site for endomorphin-1.
    Lengyel I; Toth F; Biyashev D; Szatmari I; Monory K; Tomboly C; Toth G; Benyhe S; Borsodi A
    J Physiol Pharmacol; 2016 Aug; 67(4):605-616. PubMed ID: 27779481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists.
    Gentilucci L; Tolomelli A; De Marco R; Spampinato S; Bedini A; Artali R
    ChemMedChem; 2011 Sep; 6(9):1640-53. PubMed ID: 21721130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of potential affinity labels derived from endomorphin-2.
    Choi H; Murray TF; Aldrich JV
    J Pept Res; 2003 Feb; 61(2):58-62. PubMed ID: 12492899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomorphins and related opioid peptides.
    Okada Y; Tsuda Y; Bryant SD; Lazarus LH
    Vitam Horm; 2002; 65():257-79. PubMed ID: 12481550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural function of C-terminal amidation of endomorphin. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid, studied by 1H-NMR spectroscopy, molecular calculation, and X-ray crystallography.
    In Y; Minoura K; Tomoo K; Sasaki Y; Lazarus LH; Okada Y; Ishida T
    FEBS J; 2005 Oct; 272(19):5079-97. PubMed ID: 16176278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.